ResultsIQ › Latest results › Fairchem Organics Limited
Fairchem Organics Limited Q4 FY26 results deck summary
NSE: FAIRCHEMOR · BSE: 543252
Results deck of 7 May 2026, summarised by AI from the filing.
Q4 FY26 revenue declined 3.2% Y-o-Y to ₹1,169 mn; FY30 E targets set at ₹4,300 cr revenue, ₹670 cr EBITDA and ₹405 cr PAT.
Key takeaways
- FY30 targets Management targets FY30 E revenue of ₹4,300 cr, EBITDA of ₹670 cr and PAT of ₹405 cr, subject to revision.
Fairchem Organics Limited Q1 FY27 results
As filed: Revenue ₹176 cr (+34% year on year), EBITDA ₹17.9 cr (+198% year on year), PAT ₹10.0 cr (+300% year on year), EBITDA margin 10.1% (+556 bps).
The Q1 FY27 score, against the company's own trend, is for premium members.
Earlier results and the share price after them
- Q4 FY26: Revenue ₹117 cr (−3% year on year), EBITDA ₹8.0 cr (+61% year on year), PAT ₹3.7 cr (+269% year on year), EBITDA margin 6.9% (+274 bps). Score 69 of 100, Above trend. Revenue growth was in line with the company's own trend; EBITDA growth was above it; profit growth was well above it. EBITDA margin rose 274 bps year on year. Share price after the results: −4.6% in 30 days (Nifty 500: −2.9%).
- Q3 FY26: Revenue ₹100 cr (−12% year on year), EBITDA ₹4.2 cr (−54% year on year), PAT −₹0.1 cr (−87% year on year), EBITDA margin 4.2% (−373 bps). Score 37 of 100, Below trend. Revenue, EBITDA and profit before exceptional items growth were below the company's own trend. EBITDA margin fell 373 bps year on year. Revenue fell 11% from last quarter. Share price after the results: −8.4% in 28 days (Nifty 500: −4.1%).
- Q2 FY26: Revenue ₹112 cr (−19% year on year), EBITDA ₹5.0 cr (−44% year on year), PAT ₹1.0 cr (−75% year on year), EBITDA margin 4.5% (−201 bps). Score 32 of 100, Below trend. Revenue, EBITDA and profit growth were below the company's own trend. EBITDA margin fell 201 bps year on year. Tax rate 100%. Revenue fell 15% from last quarter. Share price after the results: −6.5% in 28 days (Nifty 500: +1.3%).
- Q1 FY26: Revenue ₹131 cr (−21% year on year), EBITDA ₹6.0 cr (−74% year on year), PAT ₹1.0 cr (−93% year on year), EBITDA margin 4.6% (−936 bps). Score 26 of 100, Below trend. Revenue, EBITDA and profit growth were below the company's own trend. EBITDA margin fell 936 bps year on year. Tax rate 0%. Share price after the results: −7.4% in 30 days (Nifty 500: +2.8%).
- Q4 FY25: Revenue ₹121 cr (−25% year on year), EBITDA ₹5.0 cr (−75% year on year), PAT ₹1.0 cr (−92% year on year), EBITDA margin 4.1% (−829 bps). Score 21 of 100, Below trend. Revenue growth was well below the company's own trend; EBITDA and profit growth were below it. EBITDA margin fell 829 bps year on year. Tax rate 100%. Profit fell 75% from last quarter. Share price after the results: +12.7% in 30 days (Nifty 500: +3.1%).
- Q3 FY25: Revenue ₹114 cr (−23% year on year), EBITDA ₹9.0 cr (−55% year on year), PAT ₹4.0 cr (−67% year on year), EBITDA margin 7.9% (−562 bps). Score 23 of 100, Below trend. Revenue and profit growth were well below the company's own trend; EBITDA growth was below it. EBITDA margin fell 562 bps year on year. Revenue fell 18% from last quarter.
- Q2 FY25: Revenue ₹139 cr (−9% year on year), EBITDA ₹9.0 cr (−47% year on year), PAT ₹4.0 cr (−60% year on year), EBITDA margin 6.5% (−471 bps). Score 6 of 100, Below trend. EBITDA margin fell 471 bps year on year. Not enough history for a trend yet: scored on growth alone. Revenue fell 16% from last quarter.
Past price moves after results do not indicate future moves. Not a recommendation.
Fairchem Organics Limited earnings call, investor presentation and press release summaries
- Q1 FY27: Earnings call (28 Jul 2026), Results deck (27 Jul 2026)
- Q4 FY26: Earnings call (7 May 2026), Results deck (7 May 2026)
- Q3 FY26: Earnings call (9 Feb 2026), Results deck (7 Feb 2026)
- Q2 FY26: Earnings call (11 Nov 2025), Results deck (10 Nov 2025)
- Q1 FY26: Earnings call (13 Aug 2025), Results deck (12 Aug 2025)
- Q4 FY25: Earnings call (30 May 2025), Results deck (28 May 2025)
Figures from the company's filings with NSE and BSE. Not investment advice.